Ambey Laboratories Limited — Others, 09-04-2025: Action(s) taken or orders passed

Ambey Laboratories Limited received a Warning Letter from the National Stock Exchange for mistakenly disclosing the Permanent Account Number (PAN) of its CEO in a previous announcement. The company has taken corrective steps to prevent future lapses and has communicated modifications made to the disclosure. While the violation is serious, it does not appear to have a direct impact on the company's financials or operations. For investors, this incident reflects a need for heightened compliance vigilance but poses no immediate financial risk, suggesting a stable outlook moving forward.